Effects of saline substitution on responding and plasma corticosterone in rats trained to self-administer different doses of cocaine.
Research from our laboratory has explored the role of the hypothalamo-pituitary-adrenal (HPA) axis in cocaine reinforcement. These experiments were designed to determine the involvement of the HPA axis in extinction. Male Wistar rats were trained to self-administer cocaine [0.125, 0.25, or 0.5 mg/kg/infusion (inf)] and food pellets (45 mg) under a multiple, alternating schedule of reinforcement. When self-administration was stable, saline was substituted for cocaine. Blood samples were taken at the end of the sessions following cocaine self-administration, the first exposure to saline substitution (first); and once the criteria for extinction were met (final). Plasma corticosterone was measured using radioimmunoassays. Although there was a significant increase in the number of infusions obtained during the first saline substitution test by rats trained with 0.5 mg/kg/inf of cocaine, there was a decrease in infusions received when 0.125 mg/kg/inf of cocaine was tested. Following repeated exposure to the extinction conditions, responding by rats trained to self-administer all three doses of cocaine was decreased to similar levels. In addition, there were significant differences in plasma corticosterone in rats trained with different doses of cocaine. Lever-pressing behavior and plasma corticosterone varied during extinction in relation to the training dose of cocaine and according to whether the rats had been exposed to single or repeated extinction testing. These data are discussed in terms of the potential difficulties involved in interpreting the effects of compounds intended to reduce drug reinforcement.
Peltier
R L
RL
Department of Pharmacology and Therapeutics, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, USA. rpelti@lsuhsc.edu
Guerin
G F
GF
Dorairaj
N
N
Goeders
N E
NE
D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D019970:Cocaine-Related Disorders / Q000523:psychology*; D003216:Conditioning, Operant / Q000187:drug effects*; D003345:Corticosterone / Q000097:blood*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005108:Extinction, Psychological / Q000187:drug effects; D007262:Infusions, Intravenous; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012055:Reinforcement Schedule; D012646:Self Administration
D018765:Dopamine Uptake Inhibitors; D003042:Cocaine; D003345:Corticosterone